Related Experiment Videos
Peptide YY: a potential therapy for obesity
1Centre for Diabetes and Endocrinology, University College London, Rayne Institute, 5 University Street, London WC1E 6JJ, UK.
Current Drug Targets
|March 22, 2005
Summary
Peptide tyrosine tyrosine (PYY) hormone reduces food intake and body weight. Targeting PYY may offer a new strategy for obesity treatment due to its role in satiety signals.
Area of Science:
- Endocrinology
- Neuroscience
- Pharmacology
Background:
- Obesity is a major health epidemic with limited effective pharmacological treatments.
- Understanding body weight regulation is key to developing new obesity therapies.
- Gut hormones like PYY are emerging as important physiological regulators of appetite.
Purpose of the Study:
- To investigate the role of peptide tyrosine tyrosine (PYY) in regulating food intake and body weight.
- To explore PYY as a potential therapeutic target for obesity treatment.
Main Methods:
- Review of studies on PYY administration in rodents and humans.
- Analysis of PYY's mechanism of action involving Y2 receptors and the arcuate nucleus (ARC).
- Examination of PYY levels in lean and obese subjects.
Main Results:
- Peripheral PYY administration reduces feeding in rodents and humans.
- Obese individuals exhibit lower fasting and postprandial PYY levels.
- Rodent studies show chronic PYY infusion reduces food intake, body weight, and adiposity.
Conclusions:
- PYY is a physiological regulator of food intake with potential for obesity treatment.
- Therapeutic strategies may involve Y2 agonists, PYY administration, or enhancing endogenous PYY release.